Showing 1 - 10 of 18
Persistent link: https://www.econbiz.de/10003466976
Persistent link: https://www.econbiz.de/10009557993
Persistent link: https://www.econbiz.de/10009558021
Persistent link: https://www.econbiz.de/10002825202
Persistent link: https://www.econbiz.de/10001534870
Persistent link: https://www.econbiz.de/10001891112
Designing benefits for the growing platform workforce in the U.S. poses significant challenges. While platform workers need protection against unforeseen shocks, work that is often part time and spread across multiple platforms makes the traditional benefits model untenable. This paper reports...
Persistent link: https://www.econbiz.de/10012938705
We analyze whether receiving care from higher-priced hospitals leads to lower mortality. We overcome selection issues by using an instrumental variable approach which exploits that ambulance companies are quasi-randomly assigned to transport patients and have strong preferences for certain...
Persistent link: https://www.econbiz.de/10012938778
We empirically assess the potential financial impact of future gene therapies on the US economy. After identifying 109 late-stage gene therapy clinical trials currently underway, we estimate the number of new and existing patients with corresponding diseases to be treated by these gene...
Persistent link: https://www.econbiz.de/10012510507
The Medicare Part D Prescription Drug Plan represents the most significant privatization of the delivery of a public insurance benefit in recent history, with dozens of private insurers offering a wide range of products with varying prices and product features; the typical elder had a choice of...
Persistent link: https://www.econbiz.de/10012463888